Study outcomes The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke, over a 4.5-year follow-up period, consistent with the SOUL trial
### "The peptide powder dissolved very quickly, almost immediately" This is normal for high-quality lyophilized retatrutide
Semaglutide is a widely used GLP-1 with a clear, provider-guided titration pathway
International flights, time zone changes, airport security concerns, and the logistics of keeping medication refrigerated while traveling all complicate injection schedules
Nature 304:368371 Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE (2010) Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial